1. Benefit-risk Methodology Project. Work Package 2 Report: Applicability of Current Tools and Processes for Regulatory Benefit-risk Assessment;European Medicines Agency (EMEA),2010
2. Structured Approach to Benefit-risk Assessment in Drug Regulatory Decision-making. Draft DPUFA V Implementation Plan. Fiscal Years 2013-2017;US Food and Drug Administration,2013
3. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations;Guyatt;BMJ,2008
4. Treatment preferences of patients with early rheumatoid arthritis: a discrete-choice experiment;Hazlewood;Rheumatol (United Kingdom),2016
5. High burden of adverse events is associated with reduced remission rates in early rheumatoid arthritis;Kuusalo;Clin Rheumatol,2018